These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 10354407)

  • 1. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV
    J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl] myo-inositol 1,4,5-tris(phosphate), a potent full agonist at the D-myo-inositol 1,4,5-tris(phosphate) receptor.
    Moris MA; Caron AZ; Guillemette G; Rognan D; Schmitt M; Schlewer G
    J Med Chem; 2005 Feb; 48(4):1251-5. PubMed ID: 15715492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Deoxy derivative is a partial agonist of the intracellular messenger inositol 3,4,5,6-tetrakisphosphate in the epithelial cell line T84.
    Rudolf MT; Li WH; Wolfson N; Traynor-Kaplan AE; Schultz C
    J Med Chem; 1998 Sep; 41(19):3635-44. PubMed ID: 9733488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors.
    Marchant JS; Beecroft MD; Riley AM; Jenkins DJ; Marwood RD; Taylor CW; Potter BV
    Biochemistry; 1997 Oct; 36(42):12780-90. PubMed ID: 9335535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression level of inositol trisphosphate and inositol tetrakisphosphate receptors and their influence on Ca2+ release in permeabilized HL-60 and T15 cells.
    Dreikhausen UE; Dawson AP
    Cell Calcium; 2000 Jan; 27(1):15-24. PubMed ID: 10726207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
    Wilcox RA; Challiss RA; Liu C; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Oct; 44(4):810-7. PubMed ID: 8232232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
    J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses of D- and L-myo-inositol 1,2,4,5-tetrakisphosphate and stereoselectivity of the I(1,4,5)P3 receptor binding.
    Chung SK; Shin BG; Chang YT; Suh BC; Kim KT
    Bioorg Med Chem Lett; 1998 Mar; 8(6):659-62. PubMed ID: 9871578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site.
    Lu PJ; Gou DM; Shieh WR; Chen CS
    Biochemistry; 1994 Sep; 33(38):11586-97. PubMed ID: 7918372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimers of D-myo-inositol 1,4,5-trisphosphate: design, synthesis, and interaction with Ins(1,4,5)P3 receptors.
    Riley AM; Laude AJ; Taylor CW; Potter BV
    Bioconjug Chem; 2004; 15(2):278-89. PubMed ID: 15025523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S
    Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic study of C-glucoside trisphosphates as myo-inositol trisphosphate receptor ligands. Synthesis of beta-C-glucoside trisphosphates based on the conformational restriction strategy.
    Terauchi M; Abe H; Tovey SC; Dedos SG; Taylor CW; Paul M; Trusselle M; Potter BV; Matsuda A; Shuto S
    J Med Chem; 2006 Mar; 49(6):1900-9. PubMed ID: 16539376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Ca(2+)-release activity of D- and L-myo-inositol 2,4,5-trisphosphate and D- and L-chiro-inositol 1,3,4-trisphosphate.
    Tegge W; Denis GV; Ballou CE
    Carbohydr Res; 1991 Sep; 217():107-16. PubMed ID: 1797394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate.
    Wilcox RA; Whitham EM; Liu C; Potter BV; Nahorski SR
    FEBS Lett; 1993 Dec; 336(2):267-71. PubMed ID: 8262243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-assisted total synthesis of the optical antipodes D-myo-inositol 3,4,5-trisphosphate and D-myo-inositol 1,5, 6-trisphosphate: aspects of their structure-activity relationship to biologically active inositol phosphates.
    Adelt S; Plettenburg O; Stricker R; Reiser G; Altenbach HJ; Vogel G
    J Med Chem; 1999 Apr; 42(7):1262-73. PubMed ID: 10197969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
    Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV
    Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic effect of inositol pentakisphosphate on inositol triphosphate receptors.
    Lu PJ; Shieh WR; Chen CS
    Biochem Biophys Res Commun; 1996 Mar; 220(3):637-42. PubMed ID: 8607817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-6-Deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, a mimic of d-myo-inositol 1,3,4,5-tetrakisphosphate: biological activity and pH-dependent conformational properties.
    Horne G; Maechling C; Fleig A; Hirata M; Penner R; Spiess B; Potter BV
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1262-70. PubMed ID: 15249226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.